Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus mice
Lisa Welzel, Friederike Twele, Alina Schidlitzki, et al.
Epilepsy Research (2019) Vol. 151, pp. 48-66
Closed Access | Times Cited: 20

Showing 20 citing articles:

The metabolic basis of epilepsy
Jong M. Rho, Detlev Boison
Nature Reviews Neurology (2022) Vol. 18, Iss. 6, pp. 333-347
Closed Access | Times Cited: 149
The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments
Wolfgang Löscher
Neuropharmacology (2019) Vol. 167, pp. 107605-107605
Closed Access | Times Cited: 124
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 84
Role of Adenosine in Epilepsy and Seizures
Fabio Tescarollo, Diogo M. Rombo, Lindsay K. DeLiberto, et al.
Journal of Caffeine and Adenosine Research (2020) Vol. 10, Iss. 2, pp. 45-60
Open Access | Times Cited: 56
Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies
Detlev Boison, Jong M. Rho
Neuropharmacology (2019) Vol. 167, pp. 107741-107741
Open Access | Times Cited: 51
New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?
Wolfgang Löscher, Pavel Klein
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107934-107934
Open Access | Times Cited: 40
Proof-of-concept that network pharmacology is effective to modify development of acquired temporal lobe epilepsy
Alina Schidlitzki, Pablo Bascuñana, Prashant K. Srivastava, et al.
Neurobiology of Disease (2019) Vol. 134, pp. 104664-104664
Open Access | Times Cited: 32
Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsy
Lisa Welzel, David Bergin, Alina Schidlitzki, et al.
Neurobiology of Disease (2020) Vol. 149, pp. 105227-105227
Open Access | Times Cited: 19
Pericardial Injection of Kainic Acid Induces a Chronic Epileptic State in Larval Zebrafish
Lise Heylen, Duc-Hung Pham, Ann‐Sofie De Meulemeester, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 14
Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression
Devin K. Binder, Detlev Boison, Tore Eid, et al.
Epiliepsy currents/Epilepsy currents (2020) Vol. 20, Iss. 1_suppl, pp. 14S-22S
Open Access | Times Cited: 14
Cannabidiol protects against neurotoxic reactive astrocytes-induced neuronal death in mouse models of epilepsy
Haojie Ye, Yuhui Wan, Xin Wang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Cordycepin Enhances the Therapeutic Efficacy of Doxorubicin in Treating Triple-Negative Breast Cancer
Haichen Huang, Xiaomin Li, Wenya Wu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7077-7077
Open Access | Times Cited: 1
An update on the novel methods for the discovery of antiseizure and antiepileptogenic medications: where are we in 2024?
Alan Talevi, Carolina L. Bellera
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 975-990
Closed Access | Times Cited: 1
Bumetanide potentiates the anti-seizure and disease-modifying effects of midazolam in a noninvasive rat model of term birth asphyxia
Björn Welzel, Marie Johne, Wolfgang Löscher
Epilepsy & Behavior (2023) Vol. 142, pp. 109189-109189
Closed Access | Times Cited: 2
On Complexity and Emergence: Linking the Hypotheses of Pharmacoresistance in Epilepsy
Gabriel Servilha‐Menezes, Alan Talevi, Norberto Garcia‐Cairasco
Springer eBooks (2023), pp. 39-62
Closed Access | Times Cited: 2
How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
Nian Yu, Xingjian Lin, Qing Di
Current Neuropharmacology (2020) Vol. 18, Iss. 7, pp. 624-635
Open Access | Times Cited: 5
Mechanism of Huoxue Tongluo Decoction in treatment of erectile dysfunction caused by ischemic stroke based on network pharmacology
Jisheng Wang, Hengheng Dai, Kai-ge Zhang, et al.
Chinese Herbal Medicines (2021) Vol. 13, Iss. 3, pp. 351-358
Open Access | Times Cited: 5
Network-Pharmacology and Central Nervous System Drug Development
Alan Talevi
AAPS introductions in the pharmaceutical sciences (2024), pp. 213-227
Closed Access
Drug Combinations for Antiepileptogenesis
Wolfgang Löscher
Oxford University Press eBooks (2024), pp. 1417-1418
Closed Access
MiR-324-5p inhibition after intrahippocampal kainic acid-induced status epilepticus does not prevent epileptogenesis in mice
Amanda M. McGann, Grace Westerkamp, Alisha Chalasani, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access
Page 1

Scroll to top